The University of Chicago Header Logo

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncol. 2013 Sep; 49(9):970-976.

View in: PubMed